Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/14/2025

Management of Patent Foramen Ovale (PFO)

Diagnosis and Assessment

  • The American Heart Association recommends that PFO is typically diagnosed by transthoracic echocardiography with observed flow between the left and right atrium by color Doppler ultrasonography 1
  • Transesophageal echocardiography has higher sensitivity for PFO detection compared to transthoracic imaging and is recommended in younger adults with unexplained cerebrovascular events 4
  • Sensitivity for PFO detection is increased by asking the patient to perform a Valsalva maneuver, which transiently increases right atrial pressure 4
  • When PFO closure is planned, transesophageal echocardiography is recommended for detailed visualization of atrial septal anatomy 4

Management Algorithm Based on Clinical Presentation

  • For patients under 60 years with cryptogenic stroke, the American College of Cardiology recommends PFO closure plus antiplatelet therapy, with a strong recommendation for patients with contraindications to anticoagulation 1, 2, 3
  • For patients with contraindications to anticoagulation, PFO closure plus antiplatelet therapy is strongly recommended versus antiplatelet therapy alone 1, 2, 3
  • The American College of Cardiology recommends antiplatelet therapy as first-line treatment for patients over 60 years with cryptogenic stroke, rather than PFO closure 6

Procedural Considerations for PFO Closure

  • The PFO closure procedure typically takes under 2 hours, with an in-hospital stay of usually one day 1, 2
  • Most activities can be resumed within a few days, with full recovery within a few weeks 1, 2
  • Potential risks of PFO closure include device-related adverse events (3.6% absolute risk) 1, 2

Medical Therapy Options

  • The American Heart Association recommends antiplatelet therapy options, including aspirin (75-325 mg daily) 6
  • Anticoagulation therapy, such as warfarin with target INR of 2.0-3.0, is recommended if anticoagulation is indicated 6

Special Considerations

  • For patients with concurrent atrial fibrillation, anticoagulation would be indicated regardless of PFO status, according to the American College of Cardiology 6
  • Patients with PFO should be advised to avoid activities that may increase right-to-left shunting (e.g., Valsalva maneuvers) 6